MAIA Biotechnology, Inc. Ttl Offset Amt
MAIA Biotechnology, Inc. (MAIA) had Ttl Offset Amt of $10.36 thousand as of 2026-08-21, per its S-3 filed 2026-08-21.
Financial Statements › Notes
ffd:TtlOffsetAmt · last filed 2026-08-21
- 2026-08-21: Ttl Offset Amt $10.36K.
- 2026-04-07: Ttl Offset Amt $0.00.
| Period end | Ttl Offset Amt |
|---|---|
| 2026-08-21 | $10.36K S-3 · filed 2026-08-21 |
| 2026-04-07 | $0.00 S-8 · filed 2026-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |